Clinical Trial

Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke

Name: Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke — clinical trial record (NCT07143786)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NSAIS

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A phase I/IIa clinical trial investigating the safety and preliminary efficacy of intravenous administration of human induced neural stem cell-derived exosomes for acute ischemic stroke

Trial Details

NCT Number	NCT07143786
Lead Sponsor	Xuanwu Hospital, Beijing Collaborators: Wiseheart Co.Ltd
Conditions	Ischemic Stroke, Acute
Enrollment	38 participants
Start Date	2025-10-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-27